Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Avastin (bevacizumab) – Angiogenesis Inhibitor and Cancer Therapy

Drug (Brand / Generic)

Avastin (bevacizumab)

Company / Licensee

Roche (bought from Genentech)

Therapy Class

Angiogenesis inhibitor

Product Description

Humanised anti-VEGF MAb

Current Indications

Colorectal, breast, lung, renal cell, ovarian, brain and cervical cancer

Market Sector

Oncology

Development Status

Approved in the US, Europe and other major markets
Expand
Close
Close
Close

Go Top